Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCR (Velcade, Cladribine, Rituximab) in Mantle Cell and Indolent Lymphomas
NCT00980395Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Jul 2009
- Primary completion
- Sep 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), Lymphoplasmacytic Lymphoma (LPL), small lymphocytic lymphoma (SLL), follicular lymphoma (FL), sponsored by University of Arizona. Started Jul 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
mantle cell lymphoma (MCL)marginal zone lymphoma (MZL)Lymphoplasmacytic Lymphoma (LPL)small lymphocytic lymphoma (SLL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00980395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980395.